These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


282 related items for PubMed ID: 15582125

  • 1. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
    Leclercq IA, Farrell GC, Sempoux C, dela Peña A, Horsmans Y.
    J Hepatol; 2004 Dec; 41(6):926-34. PubMed ID: 15582125
    [Abstract] [Full Text] [Related]

  • 2. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis.
    dela Peña A, Leclercq IA, Williams J, Farrell GC.
    J Hepatol; 2007 Feb; 46(2):304-13. PubMed ID: 17157947
    [Abstract] [Full Text] [Related]

  • 3. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
    Yu J, Ip E, Dela Peña A, Hou JY, Sesha J, Pera N, Hall P, Kirsch R, Leclercq I, Farrell GC.
    Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554
    [Abstract] [Full Text] [Related]

  • 4. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW, Sahai A, Malladi P, Whitington PF, Green RM.
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [Abstract] [Full Text] [Related]

  • 5. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC.
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [Abstract] [Full Text] [Related]

  • 6. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
    Larter CZ, Yeh MM, Williams J, Bell-Anderson KS, Farrell GC.
    J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
    [Abstract] [Full Text] [Related]

  • 7. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis.
    Dela Peña A, Leclercq I, Field J, George J, Jones B, Farrell G.
    Gastroenterology; 2005 Nov; 129(5):1663-74. PubMed ID: 16285964
    [Abstract] [Full Text] [Related]

  • 8. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A, Dahm F, Jochum W, Jang JH, Georgiev P, Bader M, Renner EL, Clavien PA.
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis.
    Yu J, Chu ES, Hui AY, Cheung KF, Chan HL, Leung WK, Farrell GC, Sung JJ.
    Biochem Biophys Res Commun; 2007 Apr 27; 356(1):53-9. PubMed ID: 17350593
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice.
    Sugimoto H, Okada K, Shoda J, Warabi E, Ishige K, Ueda T, Taguchi K, Yanagawa T, Nakahara A, Hyodo I, Ishii T, Yamamoto M.
    Am J Physiol Gastrointest Liver Physiol; 2010 Feb 27; 298(2):G283-94. PubMed ID: 19926817
    [Abstract] [Full Text] [Related]

  • 13. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
    McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC.
    Hepatology; 2004 Aug 27; 40(2):386-93. PubMed ID: 15368443
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul 27; 287(1):G264-73. PubMed ID: 15044174
    [Abstract] [Full Text] [Related]

  • 16. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM.
    J Gastroenterol Hepatol; 2009 Mar 27; 24(3):443-52. PubMed ID: 19226377
    [Abstract] [Full Text] [Related]

  • 17. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
    Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Li Volti G.
    Transl Res; 2012 Jun 27; 159(6):477-86. PubMed ID: 22633099
    [Abstract] [Full Text] [Related]

  • 18. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S.
    Gastroenterology; 2007 Jan 27; 132(1):282-93. PubMed ID: 17241878
    [Abstract] [Full Text] [Related]

  • 19. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 Sep 27; 48(9):4342-50. PubMed ID: 17724226
    [Abstract] [Full Text] [Related]

  • 20. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
    Locatelli I, Sutti S, Vacchiano M, Bozzola C, Albano E.
    Clin Sci (Lond); 2013 Feb 27; 124(4):279-87. PubMed ID: 22970906
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.